Literature DB >> 17507381

Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones.

Lilia Noriega-López1, Armando R Tovar, Marcela Gonzalez-Granillo, Rogelio Hernández-Pando, Bruno Escalante, Patricio Santillán-Doherty, Nimbe Torres.   

Abstract

Obesity is frequently associated with the consumption of high carbohydrate/fat diets leading to hyperinsulinemia. We have demonstrated that soy protein (SP) reduces hyperinsulinemia, but it is unclear by which mechanism. Thus, the purpose of the present work was to establish whether SP stimulates insulin secretion to a lower extent and/or reduces insulin resistance, and to understand its molecular mechanism of action in pancreatic islets of rats with diet-induced obesity. Long-term consumption of SP in a high fat (HF) diet significantly decreased serum glucose, free fatty acids, leptin, and the insulin:glucagon ratio compared with animals fed a casein HF diet. Hyperglycemic clamps indicated that SP stimulated insulin secretion to a lower extent despite HF consumption. Furthermore, there was lower pancreatic islet area and insulin, SREBP-1, PPARgamma, and GLUT-2 mRNA abundance in comparison with rats fed the casein HF diet. Euglycemic-hyperinsulinemic clamps showed that the SP diet prevented insulin resistance despite consumption of a HF diet. Incubation of pancreatic islets with isoflavones reduced insulin secretion and expression of PPARgamma. Addition of amino acids resembling the plasma concentration of rats fed casein stimulated insulin secretion; a response that was reduced by the presence of isoflavones, whereas the amino acid pattern resembling the plasma concentration of rats fed SP barely stimulated insulin release. Infusion of isoflavones during the hyperglycemic clamps did not stimulate insulin secretion. Therefore, isoflavones as well as the amino acid pattern seen after SP consumption stimulated insulin secretion to a lower extent, decreasing PPARgamma, GLUT-2, and SREBP-1 expression, and ameliorating hyperinsulinemia observed during obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507381     DOI: 10.1074/jbc.M701045200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice.

Authors:  M González-Granillo; K R Steffensen; O Granados; N Torres; M Korach-André; V Ortíz; C Aguilar-Salinas; T Jakobsson; A Díaz-Villaseñor; A Loza-Valdes; R Hernandez-Pando; J-Å Gustafsson; A R Tovar
Journal:  Diabetologia       Date:  2012-06-29       Impact factor: 10.122

2.  Insulin and SGK1 reduce the function of Na+/monocarboxylate transporter 1 (SMCT1/SLC5A8).

Authors:  Adriana López-Barradas; Tania González-Cid; Norma Vázquez; Marisol Gavi-Maza; Adriana Reyes-Camacho; Laura A Velázquez-Villegas; Victoria Ramírez; Kambiz Zandi-Nejad; David B Mount; Nimbe Torres; Armando R Tovar; Michael F Romero; Gerardo Gamba; Consuelo Plata
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

3.  Ameliorative effects of Monascus pilosus-fermented black soybean (Glycine max L. Merrill) on high-fat diet-induced obesity.

Authors:  Hong-Geun Oh; Young-Rye Kang; Hak-Yong Lee; Jung-Hoon Kim; Eun-Hye Shin; Bong-Gun Lee; Sang-Hoon Park; Dae-In Moon; Ok-Jin Kim; In-Ae Lee; Jongkeun Choi; Ji-Ean Lee; Kwang-Hyun Park; Joo-Won Suh
Journal:  J Med Food       Date:  2014-08-12       Impact factor: 2.786

4.  Maternal soybean diet during lactation alters breast milk composition and programs the lipid profile in adult male rat offspring.

Authors:  Adriana Moura Vieira; Poliana Guiomar de Almeida Brasiel; Maíra Schuchter Ferreira; Kacia Mateus; Mariana Sarto Figueiredo; Patrícia Cristina Lisboa; Egberto Gaspar de Moura; José Otavio do Amaral Corrêa; Fernando Cesar Ferraz Lopes; Paulo Henrique Fonseca da Silva; Céphora Maria Sabarense; Sheila Cristina Potente Luquetti Dutra; Aline Silva de Aguiar
Journal:  Endocrine       Date:  2018-03-08       Impact factor: 3.633

Review 5.  A review on interplay between obesity, lipoprotein profile and nutrigenetics with selected candidate marker genes of type 2 diabetes mellitus.

Authors:  Mustansir Bhori; Varuni Rastogi; Kanchanlata Tungare; Thankamani Marar
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

Review 6.  Impact of dietary polyphenols on carbohydrate metabolism.

Authors:  Kati Hanhineva; Riitta Törrönen; Isabel Bondia-Pons; Jenna Pekkinen; Marjukka Kolehmainen; Hannu Mykkänen; Kaisa Poutanen
Journal:  Int J Mol Sci       Date:  2010-03-31       Impact factor: 5.923

7.  Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions.

Authors:  Marguerite A Klein; Richard L Nahin; Mark J Messina; Jeanne I Rader; Lilian U Thompson; Thomas M Badger; Johanna T Dwyer; Young S Kim; Carol H Pontzer; Pamela E Starke-Reed; Connie M Weaver
Journal:  J Nutr       Date:  2010-04-14       Impact factor: 4.798

8.  Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats.

Authors:  M E Oliva; A Chicco; Y B Lombardo
Journal:  Eur J Nutr       Date:  2014-06-05       Impact factor: 5.614

9.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23

10.  Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic Disease.

Authors:  Rakesh P Patel; Stephen Barnes
Journal:  PPAR Res       Date:  2011-02-24       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.